Weidai (WEI) Stock Forecast, Price & News

Weidai (NYSE:WEI) Frequently Asked Questions

Are investors shorting Weidai?

Weidai saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 113,800 shares, an increase of 695.8% from the April 15th total of 14,300 shares. Based on an average daily volume of 417,000 shares, the days-to-cover ratio is currently 0.3 days.
View Weidai's Short Interest.

How were Weidai's earnings last quarter?

Weidai Ltd. (NYSE:WEI) posted its quarterly earnings results on Wednesday, May, 27th. The company reported ($3.42) EPS for the quarter, missing analysts' consensus estimates of $4.65 by $8.07. The firm had revenue of $101.54 million for the quarter.
View Weidai's earnings history.

When did Weidai's stock split? How did Weidai's stock split work?

Weidai shares reverse split on Wednesday, January 26th 2022. The 1-3 reverse split was announced on Wednesday, January 26th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 26th 2022. An investor that had 100 shares of Weidai stock prior to the reverse split would have 33 shares after the split.

What guidance has Weidai issued on next quarter's earnings?

Weidai updated its FY 2021 earnings guidance on Monday, April, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $109.57 million-$111.14 million.

Who are Weidai's key executives?

Weidai's management team includes the following people:

• Mr. Yao Hong, Founder, Chairman & CEO (Age 42)
• Mr. Chen Feng, Pres, CFO & Director (Age 46)
• Mr. Zhu Jianzhong, VP of Technology, R&D (Age 43)
• Mr. Wang Pengfei, VP of Brand Devel., Strategy & Compliance (Age 40)
• Mr. Ding Desheng, VP of Fin. & Risk Management, Chief Risk Officer and Director (Age 40)

Who are some of Weidai's key competitors?

Some companies that are related to Weidai include Akso Health Group (AHG), CCUR (CCUR), LM Funding America (LMFA), Dunxin Financial (DXF), Sentage (SNTG), China YiBai United Guarantee International (CBGH), Senmiao Technology (AIHS), Fincera (YUANF), (JGWEQ) (JGWEQ) and Detwiler Fenton Group (DMCD).
View all of WEI's competitors.

What other stocks do shareholders of Weidai own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Weidai investors own include AbbVie (ABBV), Carnival Co. & (CCL), Energy Transfer (ET), American Airlines Group (AAL), Baidu (BIDU), Corbus Pharmaceuticals (CRBP), NIO (NIO), Ovid Therapeutics (OVID), Primo Water (PRMW) and Voyager Therapeutics (VYGR).

When did Weidai IPO?

(WEI) raised $45 million in an IPO on Thursday, November 15th 2018. The company issued 4,500,000 shares at a price of $9.00-$11.00 per share. Morgan Stanley and Citigroup acted as the underwriters for the IPO and AMTD was co-manager.

What is Weidai's stock symbol?

Weidai trades on the New York Stock Exchange (NYSE) under the ticker symbol "WEI."

How do I buy shares of Weidai?

Shares of WEI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How much money does Weidai make?

Weidai has a market capitalization of $0.00 and generates $111.02 million in revenue each year.

How many employees does Weidai have?

Weidai employs 6,970 workers across the globe.

What is Weidai's official website?

The official website for Weidai is www.weidai.com.cn.

How can I contact Weidai?

Weidai's mailing address is NO. 9 BAIYUN ROAD SHANGCHENG DISTRICT, HANGZHOU F4, 310000. The company can be reached via phone at 8657156979013 or via email at [email protected].